News
First Patients Enrolled: 3TR Clinical Study Investigating Precision Therapy in Patients with Rheumatoid Arthritis Has Begun
Rheumatoid Arthritis (RA) is one of seven chronic diseases being investigated within the 3TR project. It is a chronic inflammatory disease that affects 0.5-1% of adults in developed countries. Uncontr...
Online Talk on 20 March 2023: The Promise of Personalised Medicine for Rheumatoid Arthritis
On 20 March 2023, from 2 to 3.30 (UK time), Costantino Pitzalis, Professor of Rheumatology at Queen Mary University of London/Centre for Experimental Medicine and Rheumatology (EMR) and leader of th...
Join the 3TR Asthma Patient Advisory Group
3TR is looking for young persons with asthma or parents of a child/teen with asthma to join the 3TR Advisory Group! The 3TR Advisory Group is organised by the European Lung Foundation (ELF), and t...
Meeting in person again – 3TR’s Third Annual Meeting in Amsterdam
After more than two years of virtual annual meetings, the 3TR consortium finally met again in person on 12-13 October in Amsterdam, the Netherlands, kindly hosted by 3TR partner AMC/VUMC. The only pre...
First Patient Enrolled: 3TR Clinical Study Investigating Personalised Therapeutic Approaches in Multiple Sclerosis Has Started
Multiple sclerosis (MS) is one of seven chronic diseases being investigated within the 3TR project. The 3TR MS clinical trial aims to identify biomarkers that predict non-response to MS-specific disea...
First face-to-face meeting in over two years
The Joint Steering Committee of the 3TR Work Package Leaders has finally met in person again on 5 April 2022. The last in-person meeting has taken place in February 2020, just half a year after the of...
First Patients Enrolled: 3TR Clinical Study Investigating Personalised Therapeutic Approaches in Systemic Lupus Erythematosus Has Started
The 3TR Systemic lupus erythematosus (SLE) studies are two of the six prospective clinical studies foreseen within the 3TR project. The SLE studies comprise on the one hand the “flare biomarker study”...
First Patients Enrolled: 3TR Asthma Biologics Cohort Aims to Identify Novel Immunological Treatment Targets in Severe Asthma
The 3TR Asthma Biologics Cohort (ABC study) is a pan-European prospective translational study aiming to improve personalized medicine for patients with severe asthma. By investigating possible immun...
Study with 3TR involvement finds link between severe asthma symptoms and psoriasis medicine
The drug risankizumab is used to treat adults with psoriasis, but whether it can improve asthma control was unclear. Now, a study released Thursday (28 October 2021) in the New England Journal of Medi...
3TR consortium gathers online for its second annual meeting
On 20-21 October, the 3TR consortium gathered once more virtually for its annual meeting. Originally planned as a face-to-face meeting in Amsterdam, the 3TR consortium again had to succumb to the COVI...
New Interview Series with Young 3TR Scientists
3TR brings together a diverse, dedicated team of science enthusiasts and visionary entrepreneurs from different thematic fields and disciplines, who strive to jointly make a difference for patients su...
IBD Biomarker Regulatory Science Webinar on 10 March 2021: 3TR Partners Host Joint Workshop with Critical Path Institute
The 3TR teams for Inflammatory Bowel Disease (IBD) and Engagement with Regulators have joined forces with the Critical Path Institute to host an IBD Biomarker Regulatory Science Webinar on Wednesday ...
First Patients Enrolled: 3TR Clinical Study Investigating Targeted Therapies in Inflammatory Bowel Disease Has Started
With the aim to advance our understanding of the molecular pathways and mechanisms linked to non-response to therapy in inflammatory bowel disease, 3TR has just started an observational open-label stu...
3TR partners launch a survey on severe asthma
University of Southampton together with the European Lung Foundation just launched a survey on the ELF website for people with asthma or parents or carers of someone with severe asthma. The survey is...
3TR Partner EFA to Hold Virtual Conference on Digital Health Literacy
Innovative digital tools empower allergy and respiratory patients to be in control of their healthcare. On 23 and 24 October, the “Allergy and Respiratory Patients’ Digital Conference” focuses on digi...
Raising Global Awareness for Arthritis: Today is World Arthritis Day
12 October marks World Arthritis Day. Established by Arthritis and Rheumatism International (ARI) in 1996, this global initiative aims to raise awareness of rheumatic and musculoskeletal diseases (RMD...
3TR First progress meeting: One year completed, six years ahead
On 02-03 October 2020, the 3TR consortium gathered virtually for its first progress meeting. More than 220 participants came together to discuss the progress of the project one year after its kick-off...
Advocating for Global Respiratory Health: 25 September Marks World Lung Day
Patient Organisations in 3TR Are Raising Awareness for Global Lung Health
Every year on 25 September, World Lung Day aims to raise public awareness about lung health and the global impact of lung di...
30th anniversary of the ERS Congress
The European Respiratory Society (ERS), member of the 3TR consortium, will hold its 30th annual Congress on 7-9 September 2020. Like many other events in times of the COVID-19 pandemic, the Congress w...
Starting 3TR – Largest-ever Innovative Medicine Initiative 2 (IMI2) immunology project celebrates start in Granada
On 30-31 October 2019, the 3TR consortium came together in Granada, Spain, to officially kick off the project activities. The meeting was hosted by Marta Alarcón Riquelme, 3TR Coordinator, and her tea...